npr glp-1 DR. BETSY DOVEC, #1 female weight loss surgeon and founder of @bodybybariatrics // interviewed with @npr for a radio interview and digital article on the topic of GLP-1s. Read the full interview Medicare will start a temporary

Beyond these, in the pre-clinical space, over 25 candidates have been disclosed, but our analysis of patents, company disclosures, and early-stage publications identifies nearly 70 additional undeclared pre-clinical programs

The challenge?

Semaglutide dosing typically begins low and increases gradually over 16 weeks to minimize side effects while maximizing weight loss results

It features a targeted blend of phytonutrients, including berberine, cinnamon bark oil, diindolylmethane (DIM), milk thistle extract, quercetin, and resverat

Clinically demonstrated: In as little as 4 weeks, over 82% of users experienced improved hydration, smoother fine lines, firmer skin, and a visibly lifted appearanceregaining a youthful, sculpted look even after significant weight loss